BIOVECTRA signs service agreement with Acuitas Therapeutics for unique lipid nanoparticle (LNP) delivery system used in manufacturing mRNA-based therapies

BIOVECTRA and Acuitas Therapeutics, Inc. today announced that they have entered into a technology transfer service.

Fecal Matter Transplant Shows Promise in Cirrhosis

VIENNA — Fecal microbiota transplants (FMT) helped reset gut microbiota, leading to strengthened gut barrier function and mucosal immunity in patients with cirrhosis, according to

June 26, 2023

Mithra unlocks €1.25m from Fuji Pharma in Estelle licence payment – Pharmaceutical Technology

Fuji is expecting to launch Estelle in Japan for dysmenorrhea and endometriosis in 2024. Image Credit: SurfsUp / Shutterstock. Belgium-based Mithra has received €1.25m ($1.37m)

August 3, 2023

Nuclera appoints Joseph Bertelsen as Chief Commercial Officer

Key appointment to lead global commercial launch of eProtein Discovery platform

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.